PALMOPLANTAR PUSTULOSIS
Clinical trials for PALMOPLANTAR PUSTULOSIS explained in plain language.
Never miss a new study
Get alerted when new PALMOPLANTAR PUSTULOSIS trials appear
Sign up with your email to follow new studies for PALMOPLANTAR PUSTULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets painful skin condition
Disease control TerminatedThis study tested whether the medication deucravacitinib helps control palmoplantar pustulosis, a skin condition causing painful blisters on hands and feet. About 25 adults with moderate-to-severe symptoms took the drug daily for four months. Researchers measured changes in skin …
Matched conditions: PALMOPLANTAR PUSTULOSIS
Phase: NA • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Tiny trial tests daily pill for painful hand and foot skin disease
Disease control TerminatedThis study tested a daily pill called deucravacitinib for adults with a severe, chronic skin condition that causes painful pustules on the palms and soles. The goal was to see if the treatment could reduce skin symptoms by at least 50% and improve patients' quality of life over 2…
Matched conditions: PALMOPLANTAR PUSTULOSIS
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
5-Year skin disease treatment study tests Long-Term safety
Disease control TerminatedThis study followed people with palmoplantar pustulosis (a chronic skin condition causing painful blisters on hands and feet) who had benefited from spesolimab treatment in earlier trials. The goal was to understand the long-term safety of monthly spesolimab injections over up to…
Matched conditions: PALMOPLANTAR PUSTULOSIS
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC